Shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) rose 2.8% on Friday . The stock traded as high as $25.46 and last traded at $25.46. Approximately 373,424 shares changed hands during mid-day trading, a decline of 62% from the average daily volume of 971,714 shares. The stock had previously closed at $24.76. Analysts Set […]
Shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) have earned an average rating of “Moderate Buy” from the eight ratings firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average […]
Shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) have been assigned a consensus rating of “Hold” from the eight analysts that are presently covering the stock, MarketBeat reports. Four analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price target among […]
Vir Biotechnology (NASDAQ:VIR – Get Rating) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a report issued on Friday, Zacks.com reports. According to Zacks, “Vir Biotechnology Inc. is a clinical-stage immunology company. It is focused on combining immunologic insights to treat and prevent serious infectious diseases. The […]